Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth in Population of Companion Animals and Their Owners
4.2.2 Increased Burden of Animal Zonotic Diseases
4.2.3 Growing Pet Insurance and Animal Health Investments by Pharmaceutical Companies
4.3 Market Restraints
4.3.1 Increased Pet Care Costs
4.3.2 Substandard Healthcare Facilities in Low and Middle Income Countries
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Technology
5.1.1 Immunodiagnostics
5.1.2 Clinical Biochemistry
5.1.3 Molecular Diagnostics
5.1.4 Hematology
5.1.5 Urinalysis
5.1.6 Other Technologies
5.2 By Animal Type
5.2.1 Companion Animals
5.2.1.1 Dogs
5.2.1.2 Cats
5.2.1.3 Horses
5.2.1.4 Other Companion Animals
5.2.2 Livestock Animals
5.2.2.1 Cattle
5.2.2.2 Pigs
5.2.2.3 Poultry
5.2.2.4 Other Livestock Animals
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 France
5.3.2.2 Germany
5.3.2.3 United Kingdom
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abaxis, Inc
6.1.2 Biomerieux SA
6.1.3 Heska Corporation
6.1.4 Idexx Laboratories
6.1.5 IDVet
6.1.6 Qiagen N.V.
6.1.7 Randox Laboratories, Ltd
6.1.8 Thermo Fisher Scientific
6.1.9 Virbac
6.1.10 Zoetis, Inc


7 MARKET OPPORTUNITIES AND FUTURE TRENDS